Navigation Links
Death of partner associated with increased risk of heart attack, stroke
Date:2/24/2014

The risk of heart attack or stroke is increased in the 30 days after a partner's death.

Bereavement is recognized as a risk factor for death and is associated with cardiovascular events.

The authors compared the rate of myocardial infarction (MI, heart attack) or stroke in older patients (n=30,447, 60 to 89 years of age) whose partner died to that of individuals (n=83,588) whose partners were still alive during the same period.

Fifty patients (0.16 percent) experienced MI or stroke within 30 days of their partner's death compared with 67 (0.08 percent) of controls. The increased risk of MI or stroke in bereaved men and women lessened after 30 days.

"We have described a marked increase in cardiovascular risk in the month after spousal bereavement, which seems likely to be the result of adverse physiological responses associated with acute grief. A better understanding of psychosocial factors associated with acute cardiovascular events may provide opportunities for prevention and improved clinical care."


'/>"/>

Contact: Sunil M. Shah
sushah@sgul.ac.uk
The JAMA Network Journals
Source:Eurekalert

Page: 1

Related medicine news :

1. Preventive oophorectomy reduces risk of death by 77 percent for women with BRCA mutation
2. Double mastectomy halves death risk for women with BRCA-related breast cancer
3. Australian state has higher rate of hypothermia deaths than Sweden
4. Sports medicine physical of the future could help athletes ESCAPE sudden cardiac death
5. Death row confessions and the last meal test of innocence
6. Same cell death pathway involved in three forms of blindness, Penn team finds
7. Tripling tobacco taxes worldwide would avoid 200 million tobacco deaths
8. Jesus Was Not Born On December 25th - Controversial New Novel Tells Compelling Story About His Birth, Life and Death
9. Lung cancer death rates continue to fall, helping the decrease in overall cancer death rates
10. St. Paul Treatment Center Announces New Effort to Curb Opiate-Related Deaths in Region
11. Fosamax Lawsuits Update: Rottenstein Law Group LLP Comments on Reported $28 Million Merck ‘Jaw Death’ Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... ... 2016 , ... A newly released study has found that ... accuracy of placing precordial electrodes with little cognitive effort and a high degree ... studies have shown that single electrode misplacement is one of the single largest ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec 5, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... , , ... reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 ... growing number of obesity cases, increasing government spending on healthcare, and rising ...
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page Switzerland Healthcare & Life ... , , ... stakeholders crucial insight into Switzerland ; a country located ... of the world,s most important international health institutions as well as two ... number one ranking globally in terms of ease of doing business and ...
(Date:12/4/2016)... , Dec. 4, 2016 Blueprint ... in discovering and developing targeted kinase medicines for ... from its ongoing Phase 1 trial evaluating BLU-285, ... with advanced systemic mastocytosis (SM). Blueprint Medicines is ... of D816V mutant KIT. Approximately 90 to 95 ...
Breaking Medicine Technology: